CARILION MEDICAL CENTER
1. Target Overview & Investment Thesis
CARILION MEDICAL CENTER is a 637-bed large academic medical center in nan, VA with $1.46B in net patient revenue and a -11.3% operating margin. The hospital serves a payer mix of 26.2% Medicare, 8.3% Medicaid, and 65.4% commercial.
Thesis: Undervalued. Our ML models identify $107.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.3% to -3.9% (+736bps).
| Net Revenue HCRIS | $1.46B |
| Current EBITDA COMPUTED | $-164.5M |
| Operating Margin COMPUTED | -11.3% |
| Occupancy HCRIS | 75.2% |
| Revenue / Bed COMPUTED | $2.3M |
| Net-to-Gross HCRIS | 31.6% |
| Distress Probability ML | 43.7% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -11.3% places it below the state median. Among 13 size-comparable peers (318-1274 beds), the median margin is 3.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (318-1274), prioritizing same-state peers. 13 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CARILION MEDICAL CENTER (Target) | VA | 637 | $1.46B | -11.3% |
| INOVA FAIRFAX HOSPITAL | VA | 860 | $2.41B | 20.5% |
| UNIVERSITY OF VIRGINIA MEDICAL | VA | 665 | $2.37B | 1.1% |
| VCU HEALTH SYSTEM MCV HOSPITAL | VA | 842 | $2.26B | 0.3% |
| SENTARA NORFOLK GENERAL HOSPIT | VA | 472 | $1.34B | 4.9% |
| CJW MEDICAL CENTER | VA | 612 | $1.00B | 32.8% |
| RIVERSIDE REGIONAL MEDICAL CEN | VA | 379 | $963.3M | -20.1% |
| WINCHESTER MEDICAL CENTER | VA | 455 | $694.7M | -5.8% |
| ST. MARYS HOSPITAL | VA | 363 | $688.9M | 13.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $107.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $30.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $29.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $28.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $17.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $934K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-164.5M |
| + RCM Uplift | +$107.4M |
| Pro Forma EBITDA | $-57.0M |
| Current Margin | -11.3% |
| Pro Forma Margin | -3.9% |
| WC Released (1x) | $56.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-253.0M | $-10.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-253.0M | $-93.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-227.7M | $178.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-227.7M | $127.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-278.3M | $-465.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-278.3M | $-602.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 13 hospitals with 318-1274 beds
- Same-state prioritization (n=14)
- Comp margins: P25=0.9% / P50=3.3% / P75=14.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.